» Articles » PMID: 38551934

Retrospective Analysis of Percutaneous Intervention of the Renal Artery in Transplanted Kidneys in Children and Adolescents at a Tertiary Public Hospital

Abstract

Background: This study evaluated the long-term effects of percutaneous intervention in children and adolescents with transplant renal artery stenosis (TRAS).

Methods: Twenty patients had significant stenosis (>50%) and underwent percutaneous transluminal angioplasty (PTA/stenting) (TRAS group-intervention); 14 TNS (non-significant group -control) patients did not have significant stenosis (≤50%) and were treated clinically. The combined primary endpoints were death from all causes and late graft failure. The secondary endpoints were serum creatinine (SCr), systolic blood pressure (SBP), and diastolic blood pressure (DBP).

Results: No statistically significant difference was found between TRAS-Intervention(N = 20) and TNS groups-Control (N = 14) for these clinical parameters: deaths, 1 (5.0%) vs. 0 (0.0%) (p = 1.000) and graft loss, 4 (20.0%) vs. 2 (14.3%) (p = 1.000). For the secondary endpoints, after 1 month and 1 year the values of SCr, SBP, and DBP were similar between the two groups but not statistically significant.

Discussion: In the TRAS group (intervention), the stent implantation was beneficial for treating refractory hypertension and reducing blood pressure (BP) in children and adolescents. Despite the outcomes being similar in the two groups, it can be inferred that the patients in the TRAS group (intervention) would have had a worse outcome without the percutaneous intervention.

Conclusion: TRAS treatment with stenting can be considered for children and adolescents. Because the sample in the present study comprised of only a specific population, further studies are needed for generalization.

Trial Registration: The trial was registered at clinictrials.gov with trial registration number NCT04225338.

Citing Articles

Prediction of serum neuritin and neuron-specific enolase for prognosis in patients with traumatic brain injury combined with spinal cord injury.

Pu B, Chen Y, Bi Q, Shen J, Wang L, Han Y J Med Biochem. 2025; 43(6):870-878.

PMID: 39876915 PMC: 11771968. DOI: 10.5937/jomb0-45469.


Global prevalence and contributing factors of transplant renal artery stenosis in renal transplant recipients: A systematic review and meta-analysis.

Tamara F, Fajar J, Gersom C, Wicaksono R, Tupamahu A, Huda F Narra J. 2025; 4(3):e1782.

PMID: 39816090 PMC: 11731806. DOI: 10.52225/narra.v4i3.1782.

References
1.
Abate M, Kaur J, Suh H, Darras F, Mani A, Nord E . The use of drug-eluting stents in the management of transplant renal artery stenosis. Am J Transplant. 2011; 11(10):2235-41. DOI: 10.1111/j.1600-6143.2011.03652.x. View

2.
Bull A, Piovesan A, Marchini G, Yamacake K, Antonopoulos I, Falci R . Outcomes of endovascular treatment of renal arterial stenosis in transplanted kidneys. Int Braz J Urol. 2019; 45(5):925-931. PMC: 6844355. DOI: 10.1590/S1677-5538.IBJU.2018.0737. View

3.
Pestana J . A pioneering healthcare model applying large-scale production concepts: Principles and performance after more than 11,000 transplants at Hospital do Rim. Rev Assoc Med Bras (1992). 2016; 62(7):664-671. DOI: 10.1590/1806-9282.62.07.664. View

4.
Biederman D, Fischman A, Titano J, Kim E, Patel R, Nowakowski F . Tailoring the endovascular management of transplant renal artery stenosis. Am J Transplant. 2015; 15(4):1039-49. DOI: 10.1111/ajt.13105. View

5.
Serrano O, Bangdiwala A, Vock D, Chinnakotla S, Dunn T, Finger E . Incidence and magnitude of post-transplant cardiovascular disease after pediatric kidney transplantation: Risk factor analysis of 1058 pediatric kidney transplants at the university of Minnesota. Pediatr Transplant. 2018; 22(7):e13283. DOI: 10.1111/petr.13283. View